X4 Pharmaceuticals Inc Headquarters
Looking for information about X4 Pharmaceuticals Inc Headquarters? The links below have collected all the necessary data.
Home - X4 Pharmaceuticals, Inc.
- https://www.x4pharma.com/
- Sep 01, 2021 · Home - X4 Pharmaceuticals, Inc. Our grit drives solutions for patients. Every day, we strive to advance our pipeline of innovative medicines to treat rare diseases. By targeting the CXCR4 pathway, our novel medicines are designed to restore healthy immunity in patients with rare diseases.
FAQs X4 Pharmaceuticals, Inc.
- http://investors.x4pharma.com/faqs
- Where is X4 Pharmaceutical's corporate headquarters? Our corporate headquarters are located at 61 North Beacon Street, 4th Floor, Boston, MA 02134. ... The transfer agent and registrar for the common stock of X4 Pharmaceuticals, Inc. stock is: Computershare Trust Company, N.A. 250 Royall Street Canton, Massachusetts 02021
X4 Pharmaceuticals Receives Rare Pediatric Disease ...
- http://investors.x4pharma.com/news-releases/news-release-details/x4-pharmaceuticals-receives-rare-pediatric-disease-designation
- Dec 10, 2020 · BOSTON, Dec. 10, 2020 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of novel therapies targeting diseases resulting from dysfunction of the CXCR4 pathway, today announced that it has received Rare Pediatric Disease (RPD) Designation from the U.S. Food and Drug Administration (FDA) for its lead asset, mavorixafor, for the …
X4 Pharmaceuticals Company Profile - Office Locations ...
- https://craft.co/x4-pharmaceuticals
- Mar 04, 2021 · X4 Pharmaceuticals headquarters is located at 955 Massachusetts Ave, Cambridge. Where are X4 Pharmaceuticals offices? X4 Pharmaceuticals has offices in Cambridge and Wien. How many offices does X4 Pharmaceuticals have? X4 Pharmaceuticals has 2 offices. Learn about Craft real-time company insights.Employees: 79
X4 Pharmaceuticals LinkedIn
- https://www.linkedin.com/company/x4-pharmaceuticals
- X4 Pharmaceuticals Biotechnology Boston, Massachusetts 4,696 followers A clinical-stage biopharma company focused on the development of novel therapeutics for the treatment of rare diseases.Employees: 77
X4 Pharmaceuticals Company Profile: Stock Performance ...
- https://pitchbook.com/profiles/company/119539-54
- Description. X4 Pharmaceuticals Inc is clinical-stage biopharmaceutical company. It is focused on restoring the immune system function by developing therapeutics for the treatment of rare diseases. Its molecule therapeutics are antagonists of chemokine receptor CXCR4, which have the potential to treat a broad range of rare diseases, including ...
X4 Pharmaceuticals, Inc. - AnnualReports.com
- https://www.annualreports.com/Company/x4-pharmaceuticals-inc
- X4 Pharmaceuticals is a late-stage clinical biopharmaceutical company and a leader in the discovery and development of novel therapies for the treatment of diseases resulting from dysfunction of the CXCR4 pathway, with a focus on rare diseases and those with limited treatment options.
X4 Pharmaceuticals Receives Rare Pediatric Disease ...
- https://apnews.com/press-release/globenewswire-mobile/business-corporate-news-drug-trials-pharmaceutical-manufacturing-health-care-industry-960d23654e331ec0a884fa025e5f263c
- Dec 10, 2020 · About X4 Pharmaceuticals X4 Pharmaceuticals is a late-stage clinical biopharmaceutical company and a leader in the discovery and development of novel therapies for the treatment of diseases resulting from dysfunction of the CXCR4 pathway, with a focus on rare diseases and those with limited treatment options. The company’s lead candidate, mavorixafor, is a first-in …
X4 Pharmaceuticals - Crunchbase Company Profile & Funding
- https://www.crunchbase.com/organization/x4-pharmaceuticals
- X4 Pharmaceuticals a clinical-stage oncology company developing best-in-class oral small molecule CXCR4 antagonists for the treatment. The company is developing two unique programs such as drug candidate, X4P-001, has clinical experience in over 70 subjects, and is advancing into Phase 1/2 trials in refractory clear cell renal cell carcinomaFounder: Henri Termeer
X4 Pharmaceuticals Promotes Mary DiBiase, Ph.D. to Chief
- https://www.globenewswire.com/news-release/2021/09/08/2293360/0/en/X4-Pharmaceuticals-Promotes-Mary-DiBiase-Ph-D-to-Chief-Operating-Officer.html
- 1 day ago · BOSTON, Sept. 08, 2021 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of novel therapies targeting diseases of the immune system resulting ...
Have you found X4 Pharmaceuticals Inc Headquarters information?
On our site you can find many other information about headquarters of any company. Research information about other companies.